Yaojin Peng
Medical School
University of Chinese Academy of Sciences
Beijing
Language: English, Chinese, German
Contact
Bioethics Governance Stem Cells Ethics Review Human Embryo Research Mitochondrial Replacement Synthetic Biology Biotechnology Biosafety Biosecurity
Areas of Focus
  • Bioethics and Governance
  • Science and Technology Policy and Management
Work Experience
  • 2018-12 to Present - Chinese Academy of Sciences, Institute of Zoology - Associate Researcher
  • 2021-06-22 to Present - Director, Life Sciences and Medicine Subcommittee, CAS Committee on Science and Technology Ethics
  • 2020-05-11 to Present - Member, ISO/TC276 Biotechnology Committee
  • 2020-02-24 to Present - Visiting Researcher, Centre for AI and Law, Singapore Management University
  • 2019-12-05 to Present - Researcher, Center for Bioethics, Huazhong University of Science and Technology
  • 2019-11-14 to Present - Secretary-General, Ethics Working Committee, Chinese Society for Cell Biology
  • 2019-09-08 to Present - Member, Expert Committee, National Stem Cell Resource Bank Innovation Alliance
  • 2019-09-02 to Present - Deputy Director, Biomedical Ethics Committee, Institute of Zoology, Chinese Academy of Sciences
Academic Background & Achievements
  • 2013-09 to 2018-09 PhD: Maastricht University
  • 2010-09 to 2013-07 Master's: Graduate School of Chinese Academy of Social Sciences
  • 2005-09 to 2009-07 Bachelor's: University of Science and Technology Beijing
Publications
  • The variability of judicial decisions in the stem cell industry in China, 11th Author, 2023
  • Technical specifications for ethics review of human stem cell research, 11th Author, 2023
  • 人-动物嵌合体研究的技术-伦理张力, 11th Author, 2023
  • Acting on ethics and governance of aging research, 11th Author, 2023
  • 人体生物样本知情同意退出制度重塑, 2nd Author, 2022
  • 线粒体置换技术的挑战及其规制, 4th Author, 2022
  • A framework for the responsible reform of the 14-day rule in human embryo research, 11th Author, 2022
  • 人类胚胎研究\"14天规则\"的挑战与出路, 1st Author, 2022
  • 应对生物技术变革与伦理新挑战的中国方略, 1st Author, 2021
  • 合成生物学时代:生物安全、生物安保与治理, 1st Author, 2020
  • Stem cell therapy advertisements in China: infodemic, regulations and recommendations, 11th Author, 2020
  • Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China, 11th Author, 2020
  • 这是生物技术的时代,也是生物安全的时代, 2nd Author, 2020
  • 生命科技伦理问题与治理策略——以人-动物嵌合体研究为例, 1st Author, 2020
  • “设计婴儿”:我们将怎样面对, 1st Author, 2019
  • Patent Term Extension in the Pharmaceutical Sector: An Asian Comparative Perspective, 1st Author, 2019
  • The morality and ethics governing CRISPR-Cas9 patents in China, 11th Author, 2016
  • 中国干细胞知识产权保护的困境与对策, 1st Author, 2016
  • The patentability of human embryonic stem cell technology in China, 11th Author, 2016
  • PATENTING HUMAN EMBRYONIC STEM CELL RELATED INVENTIONS IN CHINA: A COMPARATIVE PERSPECTIVE, 1st Author, 2018
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.